Acquired Company
Horizon Therapeutics plc completed the acquisition of Viela Bio, Inc. on 3/15/2021 for $53.00 per share in cash.
Show more
Pharmaceutical Preparation Manufacturing
Manufacturing
Start AI Chat
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$53.01
Open
$53.01
Volume
N/A
Day Range
$53.01 - $53.01
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
09/30/24
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|